This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Aclarion partners Institute of Neuro...
Business partnership agreement

Aclarion partners Institute of Neuro Innovation

Analysis based on 7 articles · First reported Jun 03, 2026 · Last updated Jun 03, 2026

Sentiment
60
Attention
3
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The agreement between Aclarion and the Institute of Neuro Innovation is likely to positively impact Aclarion's stock price due to expanded market reach and increased real-world evidence for its Nociscan platform. This partnership could also lead to broader adoption of Nociscan, benefiting the healthcare technology sector.

Healthcare Technology Medical Devices Biotechnology
Event Summary

Aclarion, a healthcare technology company, announced an agreement with the Institute of Neuro Innovation (INI) to expand the availability of its Nociscan platform in the greater Los Angeles area. This partnership will enable the INI team, led by neurosurgeon Amir Vokshoor, to generate real-world evidence comparing Nociscan's chemical biomarker data with SPECT-CT bone metabolic information. The goal is to enhance diagnostic precision for chronic low back pain, a condition affecting approximately 266 million people worldwide. Nociscan is an evidence-supported SaaS platform that noninvasively helps physicians distinguish between painful and nonpainful discs in the lumbar spine, demonstrating a 97% surgical success rate when Nociscan-positive discs are treated.

Entities Involved
oth
Aclarion
Aclarion has expanded the availability of its Nociscan platform through an agreement with the Institute of Neuro Innovation, supporting its growth strategy and generation of real-world evidence. This partnership is expected to enhance its market presence and data assets.
Importance 100.0 Sentiment 70.0
oth
Institute of Neuro Innovation
The Institute of Neuro Innovation has partnered with Aclarion to offer the Nociscan platform, enhancing its diagnostic capabilities for chronic low back pain and contributing to real-world evidence generation.
Importance 80.0 Sentiment 60.0
per
Amir Vokshoor
Amir Vokshoor, founder of the Institute of Neuro Innovation, will lead the team in utilizing Aclarion's Nociscan platform to generate real-world evidence and improve treatment decisions for chronic low back pain.
Importance 70.0 Sentiment 50.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.